SCHEMBL3823829

SCHEMBL3823829

CCCCCCCCC=CCCCCCCCC(=O)N1CC(C(=O)OCC(CC)CCCC)CC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
CYP3A4 P08684 2/20 0.44
ATM Q13315 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
DGKA P23743 1/20 0.42
PRKCE Q02156 1/20 0.38
PRKCQ Q04759 1/20 0.38
PRKCD Q05655 1/20 0.38
PRKCA P17252 1/20 0.38
PRSS1 P07477 1/20 0.37
PRSS2 P07478 1/20 0.37
PRSS3 P35030 1/20 0.37
LPAR1 Q92633 6/20 0.37
LPAR4 Q99677 3/20 0.37
LPAR2 Q9HBW0 3/20 0.37
LPAR3 Q9UBY5 3/20 0.37
ENPP2 Q13822 2/20 0.36
LPAR5 Q9H1C0 2/20 0.36
CES2 O00748 1/20 0.36
LPAR6 P43657 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3825325 0.90 DGKA (0.45) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL3823823 0.84 MEN1 (0.40) TSHRCYP3A4ATMTDP1PRSS1
SCHEMBL3823832 0.84 MEN1 (0.40) TSHRCYP3A4ATMTDP1PRSS1
SCHEMBL14990529 0.83 BRD4 (0.44) CYP3A4ATMTDP1DGKATRPV1
SCHEMBL14990528 0.83 BRD4 (0.44) CYP3A4ATMTDP1DGKATRPV1
SCHEMBL1360711 0.80 PPARG (0.47) TSHRCYP3A4ATMTDP1ALDH1A1
SCHEMBL3823547 0.76 BRD4 (0.51) TSHRCYP3A4ATMTDP1PRSS1
SCHEMBL333602 0.76 TDP1 (0.77) TSHRCYP3A4ATMTDP1DGKA
SCHEMBL9838603 0.76 TDP1 (0.77) TSHRCYP3A4ATMTDP1DGKA
SCHEMBL10657519 0.76 TDP1 (0.77) TSHRCYP3A4ATMTDP1DGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722589-B2 Use of 1-alkyl-5-oxopyrrolidine-3-carboxylic esters as gas hydrate inhibitors with improved biodegradability CLARIANT FINANCE (BVI) LIMITED (VG) 2014-05-13 US disclosed
US-20090042747-A1 Use of 1-alkyl-5-oxopyrrolidine-3-carboxylic esters as gas hydrate inhibitors with improved biodegradability CLARIANT INTERNATIONAL LTD. 2009-02-12 US disclosed